Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Angiomax. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101475631B reveals a scalable liquid-phase route for Bivalirudin, offering significant cost reduction in API manufacturing and eliminating toxic HF cleavage steps.